Paediatric Consumer Health in Belgium

Abstract
The COVID-19 pandemic had a notably negative impact on paediatric consumer health in Belgium in 2020 and the second half of 2021. The closure of schools and kindergartens during lockdowns resulted in lower rates of transmission of ailments between children, with child-based illnesses typically breaking out in such environments. The rate of seasonal ailments such as the common cold and influenza were almost negated by the sanitary and precautionary measures put in place to safeguard against the S...

Euromonitor International's Paediatric Consumer Health in Belgium report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2017-2021, allowing you to identify the sectors driving growth. Forecasts to 2026 illustrate how the market is set to change.

Product coverage: Nappy (Diaper) Rash Treatments, Paediatric Analgesics, Paediatric Cough, Cold and Allergy Remedies, Paediatric Dermatologicals, Paediatric Digestive Remedies, Paediatric Vitamins and Dietary Supplements.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Paediatric Consumer Health market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Content
Paediatric Consumer Health in Belgium

List Of Contents And Tables

PAEDIATRIC CONSUMER HEALTH IN BELGIUM
KEY DATA FINDINGS
2022 DEVELOPMENTS
More seasonal ailments but ongoing parental reluctance to self-medicate children leads to depressed sales
Sales still driven by paediatric acetaminophen and paediatric cough, cold and allergy remedies
Janssen-Cilag consolidates its leadership ahead of Boots Healthcare
PROSPECTS AND OPPORTUNITIES
An additional threat for paediatric remedies: the risk of shortage
Continuous growth of laxatives and cough, cold and allergy (hay fever) remedies but probable ongoing distrust of paediatric ibuprofen and aspirin
Medical devices and products with a more natural positioning to see further emergence
CATEGORY DATA
Table 1 Sales of Paediatric Consumer Health by Category: Value 2017-2022
Table 2 Sales of Paediatric Consumer Health by Category: % Value Growth 2017-2022
Table 3 Sales of Paediatric Vitamins and Dietary Supplements by Type: % Value 2017-2022
Table 4 NBO Company Shares of Paediatric Consumer Health: % Value 2018-2022
Table 5 LBN Brand Shares of Paediatric Consumer Health: % Value 2019-2022
Table 6 Forecast Sales of Paediatric Consumer Health by Category: Value 2022-2027
Table 7 Forecast Sales of Paediatric Consumer Health by Category: % Value Growth 2022-2027
CONSUMER HEALTH IN BELGIUM
EXECUTIVE SUMMARY
Consumer health in 2022: The big picture
2022 key trends
Competitive landscape
Retailing developments
What next for consumer health?
MARKET INDICATORS
Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2017-2022
Table 9 Life Expectancy at Birth 2017-2022
MARKET DATA
Table 10 Sales of Consumer Health by Category: Value 2017-2022
Table 11 Sales of Consumer Health by Category: % Value Growth 2017-2022
Table 12 NBO Company Shares of Consumer Health: % Value 2018-2022
Table 13 LBN Brand Shares of Consumer Health: % Value 2019-2022
Table 14 Penetration of Private Label in Consumer Health by Category: % Value 2017-2022
Table 15 Distribution of Consumer Health by Format: % Value 2017-2022
Table 16 Distribution of Consumer Health by Format and Category: % Value 2022
Table 17 Forecast Sales of Consumer Health by Category: Value 2022-2027
Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2022-2027
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
DISCLAIMER
DEFINITIONS
SOURCES
Summary 1 Research Sources